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Tbjective: This prospective study compared clinical outcomes after heart surgery
etween three groups of infants with congenital heart disease. One group received
ilutional conventional ultrafiltration (group D), another received modified ultrafil-
ration (group M), and a third group received both dilutional conventional and
odified ultrafiltration (group B). We hypothesized that group B patients would
ave the best clinical outcome.
ethods: Children younger than 1 year undergoing heart surgery for biventricular
epair by the same surgeon were randomly allocated to one of the three study
roups. Patient management was standardized, and intensive care staff were blinded
o group allocation. Primary outcome measure was duration of postoperative me-
hanical ventilation. Other outcome measures recorded included total blood prod-
cts transfused, duration of chest tube in situ, chest tube output, and stays in
ntensive care and in the hospital.
esults: Sixty infants completed study protocol. Mean age and weight were as
ollows: group D (n  19), 61 days, 4.3 kg; group M (n  20), 64 days, 4.5 kg;
nd group B (n  21), 86 days, 4.4 kg. Preoperative and intraoperative
haracteristics were similar between groups. Ultrafiltrate volumes obtained were
96  93 mL/kg in group D, 105  33 mL/kg in group M, and 261  113 mL/kg
n group B. There were no significant differences between groups for any
utcome variable. Technical difficulties prevented completion of modified ul-
rafiltration in 2 of 41 infants.
onclusion: There was no clinical advantage in combining conventional and mod-
fied ultrafiltration. Because clinical outcomes were similar across groups, relative
isks of the ultrafiltration strategies may influence choice.
uring cardiopulmonary bypass (CPB) for cardiac surgery, children are sub-
jected to anticoagulation, hemodilution, hypothermia, nonpulsatile blood
flow, and exposure of blood to nonendothelialized surfaces. In response to
hese nonphysiologic conditions, patients initiate a systemic inflammatory response
yndrome (SIRS) that increases total body water and may result in multi-organ
ysfunction. SIRS is considered a major contributor to the increased morbidity and
ortality associated with CPB in children.1,2
Ultrafiltration can ameliorate the effects of CPB by removing free water and
ome inflammatory mediators.3,4 Conventional ultrafiltration (CUF) is perform
uring CPB.5 If fluid is added to the CPB circuit during CUF to increase the 
f ultrafiltrate, the process is dilutional ultrafiltration (DCUF). Modified ultrafiltra-
ion (MUF) is conducted after CPB.6 Ultrafiltration of the prime (PUF) before 
nset of CPB is sometimes performed if the CPB circuit is primed with packed red
he Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 6 1291
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Dlood cells (PRBCs).7 All these ultrafiltration methods f
ardiac operations have been found clinically beneficial
elative to unfiltered control CPB4-6,8-10 and can be use
eparately or combined in the same patient to provide po-
entially additive positive effects.11
Differences between DCUF and MUF merit consideration.
echnically, DCUF demands little of the surgeon’s attention,
hereas MUF increases the complexity of the immediate post-
PB period. DCUF enables removal of inflammatory media-
ors throughout CPB and does not prolong the duration of
PB, but it can only achieve moderate hemoconcentration.
UF provides more effective hemoconcentration,12,13 but it
xtends the duration of patient exposure to nonendothelial
urfaces14 and does not reduce plasma concentrations 
nflammatory mediators in children.15 Both techniques ar
onsidered safe.
Controversy remains regarding the optimal ultrafiltra-
ion strategy.5,8,13,16-21 Surrogate outcome measures
uch as cytokine levels, have not been helpful in guiding
he choice of ultrafiltration in children, because the rela-
ionships between plasma concentrations of proinflam-
atory and anti-inflammatory cytokines and patient out-
ome are poorly defined.12,13,15 Gaynor12 stated, “Further
tudies are necessary to identify patients most likely to
enefit from ultrafiltration, and to define standard proto-
ols for use of ultrafiltration in infants and neonates
ndergoing CPB.”
The aim of our prospective study was to compare clinical
utcome after cardiac operations between three groups of
nfants. One group of patients received DCUF only, another
roup received MUF only, and the third group received both
CUF and MUF. On the premise that ultrafiltration is
eneficial, the protocol was designed to optimize each ul-
rafiltration strategy. Study hypothesis was that the infants
ho underwent both DCUF and MUF would have a better
Abbreviations and Acronyms
ANOVA analysis of variance
CPB  cardiopulmonary bypass
CUF  conventional ultrafiltration
DCUF  dilutional ultrafiltration
DHCA  deep hypothermic circulatory arrest
ICU  intensive care unit
MUF modified ultrafiltration
PRBCs  packed red blood cells
PUF  ultrafiltration of prime before onset of
CPB
SIRS  systemic inflammatory response syndromelinical outcome than the other groups. a
292 The Journal of Thoracic and Cardiovascular Surgery ● Decaterials and Methods
he study protocol was approved by the institutional review
oard, and informed parental consent was obtained before patient
nrollment.
tudy Population
nfants younger than 1 year were enrolled in this prospective,
andomized study. With a random numbers table, patients were
llocated to receive DCUF (group D), MUF (group M), or both
CUF and MUF (group B).
Inclusion criteria were gestational age greater than 37 weeks,
ostnatal age younger than 12 months, and scheduling for cardiac
perations performed by V.M.R. Exclusion criteria were as fol-
ows: active noncardiac disease that was expected to compromise
he patient’s postoperative recovery; previous sternotomy, which
ay influence blood loss, an outcome variable; weight greater than
kg, because of the need for a CPB oxygenator of greater flow
apacity (to reduce CPB variables, the oxygenator was limited to
ne model); and single-ventricle palliation (surgeon’s preference).
nesthesia, Surgery, and CPB
nesthesia was induced with sevoflurane or ketamine (1-2 mg/kg)
nd maintained with fentanyl (30-100 g/kg), midazolam (0.1-0.4
g/kg), and rocuronium bromide, supplemented with isoflurane.
reoperative steroids were not administered.
Anticoagulation was established with an initial bovine heparin
ose of 400 U/kg, and additional heparin was administered during
PB to maintain Celite-based activated clotting time greater than
80 seconds. The dose and adequacy of anticoagulation reversal by
rotamine were guided by heparin-protamine titration. Nonpulsa-
ile CPB was performed with a hollow-fiber membrane oxygenator
Terumo Capiox RX05; Terumo Cardiovascular Systems, Ann
rbor, Mich) and nonocclusive roller pump. CPB circuit compo-
ents, setup, and prime were standardized. The circuit was primed
ith normal saline solution, 25% albumin, mannitol, sodium bi-
arbonate, calcium chloride, methylprednisolone (30 mg/kg), and
eparin. Banked PRBCs and fresh-frozen plasma were added to
chieve a hematocrit of about 30% during initiation of CPB.
ypothermia was induced in all patients, and blood gases were
egulated according to the alpha-stat regimen unless deep hypo-
hermia was required, in which case a pH-stat regimen was used
uring cooling. Myocardial preservation was achieved with cold
rystalloid cardioplegia. Transfusion therapy in the operating room
nd intensive care unit (ICU) was standardized to established
rotocols. Target post-CPB hematocrit varied from 35% to 50%,
epending on the patient’s cardiac and respiratory status. Antifi-
rinolytics were not administered.
Whenever possible, the surgeon attempted to standardize the
onduct of surgery, CPB, and ultrafiltration. Toward the end of
PB, the usual time to initiate preparations for MUF, the perfu-
ionist divulged the patient’s study group allocation to the surgeon
nd anesthesiologist.
ltrafiltration
he polysulfone hemofilter used (Minntech HPH 400; Minntech
orporation, Minneapolis, Minn) uses hollow-fiber technology
nd is rated to have a filtration cutoff to particles greater than
ember 2006
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D5,000 d molecular weight. A transmembrane pressure gradient of
t least 200 mm Hg was applied during ultrafiltration.
After the addition of blood products, hemofiltration of the CPB
ircuit prime was performed before CPB to adjust pH and elec-
rolyte concentrations and to remove inflammatory mediator22
iltrate volume from PUF ranged from 100 to 200 mL.
DCUF was performed throughout CPB to achieve a filtrate
olume of at least 120 mL/kg. Fluids (crystalloid, PRBCs, or
lasma) were added when necessary to provide sufficient volume
n the CPB circuit to permit ultrafiltration.
Arteriovenous MUF was initiated after separation from CPB by
tandard technique. Blood from the aortic cannula and from the CPB
ircuit venous reservoir was pumped through the hemofilter and then
armed by a coiled heat exchanger (Medtronic MYOtherm XP car-
ioplegia delivery system; Medtronic Inc, Minneapolis, Minn) and
eturned through the cardioplegia circuit to the patient’s venous can-
ulas. Infusion rates were adjusted to maintain appropriate central
enous or left atrial pressure. MUF was terminated when red cell
alvage of circuit contents was judged by the perfusionist to be
omplete.
ostoperative Care
he ICU staff participating in postoperative patient management
ere blinded to study group assignment. Goals for mechanical
entilator support depended on the patient’s cardiorespiratory sta-
us. Weaning from ventilator support was initiated after the patient
ad exhibited clinical stability. When the child demonstrated the
bility to sustain adequate spontaneous respiratory effort and re-
uired minimal supplemental oxygen, as assessed by arterial blood
as analysis, the child’s trachea was extubated.
ata Collection
he primary patient outcome measure was duration of postopera-
ive mechanical ventilation of the lungs. Secondary outcome mea-
ures were total volume and units of blood products transfused by
eight of infant, duration of chest tube in situ, and ICU and
ospital stays.
Data were recorded regarding patient demographics, preoper-
tive clinical status, and the ultrafiltration methods used. Aspects
f the intraoperative and postoperative courses were recorded for
he first 5 days of ICU care or until discharge from the ICU,
hichever was earlier. Details included transfusion therapy, car-
iorespiratory function and support, fluid balance, nutrition, drug
herapy, laboratory tests, perioperative adverse events, and the
ABLE 1. Demographics of the patient population
ariable Group D
o. 19
ge (d, mean  SD) 61.21  63.82
eight (kg, mean  SD) 4.27  1.29
ale sex (No.) 9/19 (47%)eriod from termination of CPB to end of surgery. 1
The Journal of Thoracicower Analysis
ith standard sample size calculation for a power of 0.80, P 
05, equal variance and effect size similar to that reported for
ostoperative duration of lung ventilation,5 the sample size re-
uired was 51 (n  17 per group). Sample size calculations
ndicated that a sample of 51 would also be appropriate for the
econdary outcome variables.
ata Analyses
ata were analyzed to ascertain whether groups D, M, and B were
imilar and could be compared. Clinical outcome was compared
etween all three groups of patients. Analysis of variance
ANOVA) was used to compare group means between the three
ypes of ultrafiltration methods for continuous outcome measures.
he Pearson 2 was used to analyze categoric variables. Longitu-
inal continuous data was analyzed with mixed effects analysis.
hen data were not normally distributed, nonparametric statistical
nalyses (Kruskall-Wallis) were used. Computations were per-
ormed with SAS 9.1 (SAS Institute, Inc, Cary, NC).
esults
ixty-two infants were enrolled in the study. Two subjects
ere excluded from data analysis for protocol violations. Of
he remaining 60 patients, 19 received DCUF only (group
), 20 received MUF only (group M) and 21 received both
CUF and MUF (group B).
Demographic characteristics of the three groups were
imilar and are presented in Table 1. Operations perfor
ncluded repair of ventricular septal defect (n  13), repair
f tetralogy of Fallot (n  12), repair of atrioventricular
eptal defect (n  12), repair of transposition of the great
rteries (n  9), repair of total anomalous pulmonary ve-
ous return (n  3), complex repair of double-outlet right
entricle (n  3), repair of multiple level obstruction of left
eart (n  2), repair of anomalous origin of coronary artery
rom pulmonary artery (n  1), resection of cardiac tumor
n  1), repair of congenitally corrected transposition (n 
), repair of cor triatriatum (n  1), repair of truncus
rteriosus (n  1), and repair of biventricular outflow ob-
truction (n  1). The operative procedure included valve
epair in 5 cases (excluding tetralogy of Fallot and atrio-
entricular septal defect repairs) and aortic reconstruction in
Group M Group B P value
20 21
4.30 73.89 86.10 104.00 .58
4.52 1.23 4.35 1.51 .84
10/20 (50%) 13/21 (62%) .6264 cases.
and Cardiovascular Surgery ● Volume 132, Number 6 1293
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DThere were no significant differences in the prevalence
f preoperative medication use or the need for preoperative
echanical ventilation. Study groups also did not differ
ignificantly with respect to preoperative hematocrit, white
lood cell count, electrolyte levels, and renal and coagula-
ion laboratory test values. Selected intraoperative charac-
eristics of patients are presented in Table 2. There we
ignificant differences between groups for duration of CPB,
uration of crossclamping, minimum core temperature dur-
ng CPB, or total heparin dose. The distributions of indi-
idual anesthesiologists and perfusionists caring for these
atients were not significantly different between groups.
roups did not differ significantly in the complexity of
ardiac operations performed. None of the patients were
ubjected to deep hypothermic circulatory arrest (DHCA).
otal volumes of ultrafiltrate obtained were 196  93
L/kg (group D), 105  33 mL/kg (group M), and 261 
13 mL/kg (group B).
ABLE 2. Intraoperative characteristics of the patient pop
haracteristic Group
omplex surgery (No.) 7/19 (37
PB prime (mL, mean  SD) 459 4
PB duration (min, mean  SD) 123 5
ortic crossclamp time (min, mean  SD) 94  1
inimum core temperature (°C, mean  SD) 26.6  5
otal heparin (units, mean  SD) 5442  1
PB, cardiopulmonary bypass.
ABLE 3. Principal outcome measures
utcome G
uration of mechanical ventilation (h)*
25%
50%
75%
uration of chest tube in situ (h)*
25%
50%
75%
otal volume of transfused blood products (mL/kg)† 237
tay in ICU (h)*
25%
50% 1
75% 3
uration in hospital (d)*
25%
50%
75%
CU, intensive care unit. *Data are presented as median and 25% and
s mean  SD, and ANOVA was computed.
294 The Journal of Thoracic and Cardiovascular Surgery ● Deco
MUF increased hematocrit values in group M from
9%  6% to 47%  6% (P  .0001) and in group B from
9%  7% to 47%  8% (P  .0001). In addition, MUF
ncreased arterial blood pressures in group M from 57 to
4 mm Hg systolic (P  .0001) and from 34 to 51 mm Hg
iastolic (P  .0001) and in group B from 58 to 76 mm Hg
ystolic (P  .0001) and from 35 to 48 mm Hg diastolic
P  .0001). Hematocrit and arterial blood pressure at
quivalent time points did not change significantly for group
patients.
The primary and secondary outcome measures are shown
n Table 3. There was no difference between groups i
uration of postoperative mechanical ventilation of the
ungs, duration of chest tube placement, or ICU and hospital
tays. Total blood product use, measured by volume per
ilogram of body weight and by units per kilogram of body
eight, also did not differ between groups. Blood products
ransfused during surgery and in the first 24 postoperative
on
Group M Group B P value
9/20 (45%) 9/21 (43%) .87
471 52 476 47 .51
142 57 146 57 .40
86 33 86 44 .90
25.1 5.3 25.1 4.8 .56
4935 1952 5200 1072 .55
D Group M Group B P value
.57
40.71 25.66
69.92 66.66
128.75 112.83
.20
48.38 47.58
88.79 94.16
162.71 115.83
87.5 223.9 91.0 262.7 138 .54
.82
101.76 118.98
212.41 164.56
332.32 256.33
.49
7 6
15 11
25 21
quartiles, and Kruskal-Wallis test was computed. †Data are presentedulati
D
%)
3
2
04
.4
111roup
27.75
48.75
76.16
62.50
71.00
86.00
.8
98.18
50.41
52.73
7
10
18
75%ember 2006
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Dours were 1.87  0.79 units/kg (group D), 1.72  0.68
nits/kg (group M), and 1.99  0.96 units/kg (group B) for
ll products combined and did not differ between groups
P  .57, ANOVA). Likewise there were no differences in
se (units per kilogram) of PRBCs (P  .55), plasma (P 
39), platelets (P  .65), or cryoprecipitate (P  .76).
ematocrit values measured at 48 postoperative hours did
ot differ significantly between groups (mean  SD group
44%  5%, group M 44%  6%, and group B 43% 
%, P  .49).
Additional clinical outcome parameters were then ana-
yzed. There were no differences between groups for the
ollowing (data not presented): pulmonary compliance and
esistance at 24 postoperative hours (P  .55 and P  .10,
espectively, ANOVA); alveolar-arterial oxygen gradient at
4 postoperative hours (P  .71, Kruskal-Wallis); systolic
lood pressure preincision, at the end of operation, and at 24
ostoperative hours (P  .64, P  .41, and P  .69,
espectively, ANOVA), doses of inotropes used during the
rst 5 days in the ICU (dopamine P  .11, milrinone P 
31, random coefficient analysis); duration that a central
enous catheter was in situ (P  .24, Kruskal-Wallis);
nterval between administration of protamine and termina-
ion of surgery (P  .71, Kruskal-Wallis); chest tube output
t 24 postoperative hours (P  .77, Kruskal-Wallis); and
alues of blood urea nitrogen and serum creatinine at 48
ostoperative hours (P  .38 and P  .30, respectively,
NOVA).
Post hoc power analysis was based on a 2-sample t-test
o resolve a 50% change in group B with actual observed
ariance and assuming an  of 0.05. The powers to resolve
0% change in outcome variables were 92% for duration of
ostoperative ventilation, 99% for duration of chest tube,
nd 99% for total volume of blood products transfused.
Of the 60 patients that completed study protocol, 2 died.
oth were in study group M and were late deaths (postop-
rative days 29 and 95) that were unlikely to be related to
he ultrafiltration technique used. Two patients (weight
.9 kg and 1.8 kg) allocated to group B were excluded from
ata analysis because the study protocol was not followed.
n both cases, the patients had received DCUF but MUF was
erminated prematurely because of systemic hypotension.
iscussion
e hypothesized that an ultrafiltration strategy that used
CUF to facilitate early modification of SIRS and MUF to
aximize hemoconcentration would provide optimal out-
ome for infants undergoing cardiac operations. Our study
ound that the combination of MUF and DCUF afforded no
dditional benefit in terms of patient outcome relative to
ither MUF or DCUF alone. Technical complications were
wice encountered during MUF. t
The Journal of ThoracicEvidence has accumulated that ultrafiltration reduces post-
perative morbidity after pediatric cardiac operations. Ultrafil-
ration has been shown to decrease total body water accumu-
ation, decrease postoperative blood loss and blood product
se, increase arterial blood pressure and improve left ventric-
lar systolic function, improve the alveolar–arterial oxygen
radient and pulmonary compliance, decrease the frequency of
ulmonary hypertensive episodes and the duration of postop-
rative ventilation, and decrease the incidence of pleural
ffusions after superior cavopulmonary connection and the
ontan procedure.12 Although the mechanisms by whi
ltrafiltration produces beneficial effects remain unclear,
urmises include reduction of tissue edema, hemoconcen-
ration, and removal of inflammatory mediators.
MUF was introduced in 1991 because CUF inadequately
imited the postoperative accumulation of total body water
n children.6 The introduction of zero balance ultrafiltratio8
nd DCUF5,23 permitted removal of large volumes of ul-
ltrate during CBP and prompted debate about the relative
erits of MUF, DCUF, and a combination of the two
echniques.6,8,16
Two recent reviews of ultrafiltration during cardiac op-
rations concur that the results of published studies are
onflicting and that further investigations are necessary to
etter define ultrafiltration strategies in the pediatric popu-
ation.12,15 Pediatric studies that have compared ultrafilt-
ion during CPB and MUF are listed in Table 4. A 
roblem that complicates interpretation of study findings is
he lack of standardization in the performance of ultrafiltra-
ion. Factors that may influence study results include type of
ltrafiltration during CPB (CUF, DCUF), type of MUF
arteriovenous, venovenous), duration of ultrafiltration dur-
ng CPB, volume of ultrafiltrate obtained, end point chosen
or termination of MUF, the type of hemofilter, use of PUF,
oncomitant anti-inflammatory therapies (such as aprotinin
r corticosteroids), patient characteristics (eg, young age,
resence of pulmonary hypertension23), CPB variables (eg
rime volume and type), and complexity of cardiac surgery
eg, use of DHCA24). Additionally, several reports of ult-
ltration were retrospective or included historical control
ubjects.
Our single-institution, prospective, randomized study
as designed to reduce confounding variables by blinding
he ICU caregivers, standardizing intraoperative and post-
perative care, and limiting the study population to infants.
lso, it was hoped that by selecting this age group, detec-
ion of differences in outcome would be enhanced, because
he benefits of ultrafiltration are more pronounced in infants
ndergoing complex cardiac operations.24 Twenty-nine of
he study patients (48%) were neonates.
Some of the beneficial effects of ultrafiltration may be
ransient and have minimal positive effect on clinical out-
and Cardiovascular Surgery ● Volume 132, Number 6 1295
c e
t
i
b
T
m
c
l trat-
e ures
d
a
p
f
m
o
i
w
C
u
 tha
d
l
v
b
t s
f
m
s
fi
w
a
i
t
r
h
p
s
t in
T  of
C
o
a
i
p
D
c
t
h n of
m
t
i erated
o
i
H
T
F
W
T
M
S
B
J
H
M
†
l
Surgery for Congenital Heart Disease Williams et al
1
CH
Dome. Keenan and colleagues25 reported that MUF, relativ
o nonultrafiltered control CPB, resulted in a significant
mprovement in lung compliance immediately after CPB
ut not at the end of surgery or 24 postoperative hours.
here were no differences between groups in duration of
echanical ventilation or ICU stay. With this in mind, we
hose outcome variables that were of clinical relevance and
ikely to influence our future choice of ultrafiltration s
gies (Table 3). None of these principal outcome meas
iffered significantly between groups. Other more subtle
nd perhaps transient outcome parameters were then com-
ared between groups, but no significant differences were
ound. Parameters included postoperative measures of pul-
onary function (compliance, resistance, alveolar–arterial
xygen gradient), cardiac function (arterial blood pressure,
notrope requirements, duration that central venous catheter
as in situ), hemostasis (duration of intraoperative post-
PB period, chest tube output), and renal function (blood
rea nitrogen, creatinine).
Review of the publications listed in Table 4 suggests
ifferences in outcome between study groups are more
ikely when the groups being compared differ greatly in the
olumes of ultrafiltrate obtained. This is not surprising,
ecause the positive benefits of ultrafiltration correlate with
he volume of filtrate removed.26 Total ultrafiltrate volume
or our study exceeded those reported in the studies sum-
arized in Table 4. A recent publication27 that demon-
trated efficacy of MUF in neonates obtained a mean ultra-
ABLE 4. Studies comparing MUF and conventional CUF i
irst author Group Age* (mo) n Ultrafiltrate (mL/k
ang18 MUF 62 24 —‡ 
CUF 44 26 —‡
hompson16 MUF 13 43 95 
CUF 9 67 68
aluf19 MUF  CUF 9 20 39 
CUF 15 21 20
ever20 MUF  CUF 9 13 —‡ 
CUF 13 14 —‡
ando5 MUF  DCUF 17 50 155 
CUF 30 50 29
ournois8 MUF  DCUF 13 10 200
MUF 6 10 30
iramatsu21 MUF  DCUF 67 11 186 
CUF 74 11 25
UF, modified ultrafiltration; CUF, conventional ultrafiltration; ICU, intensi
Target hematocrit during cardiopulmonary bypass. ‡Value not published. §
onger than 120 minutes.ltrate volume of 104 mL/kg; our MUF ultrafiltrate volume m
296 The Journal of Thoracic and Cardiovascular Surgery ● Decl  
t
as 105 mL/kg. The significant increases in hematocrit and
rterial blood pressure during MUF provide additional ev-
dence that MUF was adequately performed.3,26,27
For all our study patients, banked PRBCs were added to
he CPB circuit prime and PUF was performed. PUF is
eported to lower plasma concentrations of bradykinin and
igh–molecular weight kininogen and, relative to control
rocedures, result in less tissue edema, improved cardiore-
piratory status, and reduced durations of mechanical ven-
ilation and ICU stay.7,22,28 None of the studies listed 
able 4 ultrafiltered the heme prime before initiation
PB. It is uncertain what influence PUF had on the outcome
f our patients, but it may be that large ultrafiltrate volumes
nd early initiation of ultrafiltration are both important for
mproving clinical outcome.
There are other factors to consider. None of our study
atients were submitted to DHCA; infants undergoing
HCA particularly benefited from MUF.24,27 With the ex-
eption of the study by Thompson and associates,16 the
arget hematocrit during CPB in our study was considerably
igher than those of other studies (Table 4). Additio
ethylprednisolone to the CPB prime may have modified
he outcome of our patients. Unlike the other studies listed
n Table 4, all our patients were infants and were op
n by the same surgeon.
Although ultrafiltration during and after CPB in children
s considered safe,12 consideration of risk is warranted.25
emofiltration carries the potential for human and equip-
ildren undergoing cardiac surgery
Hct† (%) Clinical outcome
18 No difference in inotrope use, diuresis, duration of
ventilation, ICU stay18
28-30 No difference in blood product transfusions,
hemodynamics, left ventricle shortening, duration
of ventilation, ICU stay
28-30
25 No difference in inotrope use, transfusions, duration
of ventilation, ICU stay, hospital stay25
20 MUF  CUF: better hemodynamics, less bleeding
and transfusions, shorter duration of ventilation,
shorter ICU stay
20
14-18 MUF  DCUF: high-risk patients§ had less
transfusions, better oxygenation, shorter duration
of ventilation, shorter ICU stay
14-18
—‡ MUF  DCUF: less blood loss, better alveolar-arterial
oxygen gradient, shorter duration of ventilation—‡
18-28 MUF  DCUF: lower pulmonary vascular resistance
(Fontan procedure)18-28
re unit; DCUF, dilutional ultrafiltration. *Mean or median age of patients.
risk factors were neonatal age, pulmonary hypertension, and CBP durationn ch
g)
ve ca
Highent error and increases plasma heparin concentration.
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Dompared with DCUF, MUF has some additional risks. The
ortic cannula may entrain air. Removal of blood from the
ystemic circulation may result in hemodynamic instability
r impair aortopulmonary shunt flow. High flow rates
hrough the ultrafilter decrease cerebral blood flow veloci-
ies and cerebral mixed venous oxygen saturation.29 In
mall infants, the aortic cannula may be obstructive, and its
arly removal may limit or prevent use of arteriovenous
UF. MUF extends the period of patient exposure to non-
ndothelialized surfaces. Cooling of the patient will occur if
he ultrafiltered blood is inadequately warmed.
Two patients assigned to study group B did not receive
UF because of hemodynamic issues during the immediate
ost-CPB period. After assessing our data, we have opted
ot to provide MUF to infants undergoing cardiac opera-
ions, because MUF and DCUF were similarly beneficial
ut the incidence of complications, although uncommon,
as greater for MUF than for DCUF. We combine PUF and
CUF.
Selection of ultrafiltration strategies appears linked to the
onduct of CPB. Gaynor and coworkers27 retrospectively
eviewed 99 neonates who underwent the first stage of
orwood reconstruction and noted that MUF was success-
ully and safely used in all cases. DHCA was universally
sed (mean duration 45 minutes), and the mean duration of
PB support was 100 minutes. In such instances, MUF
eems a logical option because duration (and perhaps ben-
fit) of DCUF would be limited if there is no blood flow for
early half of the CPB period. At our institution, DHCA is
eldom used for the first stage of Norwood reconstruction.
The conclusions of this study of infants may not be
pplicable to older children. MUF may be desirable for
emoconcentration in bigger children, in whom avoidance
f exposure to donor blood products is feasible. Study
eaknesses should be noted. It was impossible to com-
letely blind intraoperative care providers to the method of
ltrafiltration. Most of the outcome measures pertained to
he patient’s postoperative clinical course, however, and
CU caregivers were blinded. It is possible that the study
ad insufficient power to detect differences between groups,
lthough post hoc power analysis indicates that this is
nlikely.
In summary, this prospective, randomized study of 60
nfants found no difference in clinical outcome between
atients who received DCUF only, patients who received
UF only, and patients who received both DCUF and
UF.
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